Compare NSTS & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSTS | HYFT |
|---|---|---|
| Founded | 1921 | 1983 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.6M | 66.8M |
| IPO Year | 2021 | N/A |
| Metric | NSTS | HYFT |
|---|---|---|
| Price | $13.81 | $1.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 7.6K | ★ 236.3K |
| Earning Date | 05-13-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $252,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.73 | $0.99 |
| 52 Week High | $13.82 | $3.00 |
| Indicator | NSTS | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 40.55 |
| Support Level | $13.72 | $1.17 |
| Resistance Level | $13.81 | $1.44 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 80.00 | 33.33 |
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.